Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

TTC32 Inhibitors

TTC32 inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of the Tetratricopeptide Repeat Domain 32 (TTC32) protein. TTC32 is part of the tetratricopeptide repeat (TPR) family, which consists of proteins that mediate protein-protein interactions through their characteristic TPR motifs. These motifs enable TTC32 to act as a scaffolding protein, facilitating the assembly of multi-protein complexes that are critical for various cellular processes. Though TTC32's precise biological function is not fully understood, it is thought to play a role in regulating intracellular signaling pathways, protein folding, and trafficking within the cell. By inhibiting TTC32, researchers can disrupt these protein interactions, potentially affecting key cellular functions like signal transduction and cellular organization.

The structural design of TTC32 inhibitors focuses on binding to the TPR domains or other essential regions of the protein that are critical for its interaction with other proteins. By blocking these binding sites, TTC32 inhibitors prevent the protein from assembling or stabilizing protein complexes, which in turn may impact cellular processes dependent on these interactions. The study of TTC32 inhibition allows researchers to investigate how this protein contributes to the formation and regulation of multi-protein complexes, as well as its role in maintaining cellular homeostasis. By exploring the effects of TTC32 inhibition, scientists gain insights into broader mechanisms such as protein folding, intracellular trafficking, and the regulation of signaling pathways, which rely on the proper assembly and function of protein complexes within the cell. Through the use of TTC32 inhibitors, the molecular dynamics of cellular organization and the importance of protein interactions in regulating cellular processes can be better understood.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A PI3K inhibitor that can impede the PI3K/AKT pathway, potentially affecting TTC32's activity if linked to this pathway.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Also inhibits PI3K, likely to suppress TTC32 if it's regulated by PI3K/AKT signaling.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

An MEK inhibitor that can disrupt the MAPK/ERK pathway, altering the activity of TTC32 if it's part of this signaling cascade.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Inhibits mTOR, which may affect TTC32 by altering protein synthesis and degradation pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

A p38 MAPK inhibitor, can modulate inflammatory response pathways that TTC32 may be involved in.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, potentially affecting TTC32's activity if it interacts with the JNK signaling pathway.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

A proteasome inhibitor that can stabilize the protein levels of TTC32, thereby modifying its function.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Another proteasome inhibitor that can alter the degradation rate of TTC32, influencing its cellular concentration.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

A histone deacetylase inhibitor that can change gene expression profiles, including that of TTC32.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor, can modify the epigenetic state and transcription levels of TTC32.